انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
Manage episode 386758190 series 3369804
In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, Australia. Here are the key articles we discussed:
1. Glofitamab for Relapsed/Refractory DLBCL:
https://pubmed.ncbi.nlm.nih.gov/36507690/
2. Long-term follow-up data on blinatumomab in relapsed/refractory B-cell NHL:
https://pubmed.ncbi.nlm.nih.gov/31451445/
3. Phase 1/2 study of epcoritamab in relapsed/refractory DLBCL:
https://pubmed.ncbi.nlm.nih.gov/36548927/
4. Phase 2 trial of mosunetuzumab in relapsed/refractory follicular lymphoma:
https://pubmed.ncbi.nlm.nih.gov/35803286/
5. Phase 1 trial of odronextamab in relapsed/refractory B-cell NHL:
https://pubmed.ncbi.nlm.nih.gov/35366963/
6. Epcoritamab + R2 in high-risk follicular lymphoma:
https://meetings.asco.org/abstracts-presentations/218265
7. Glofitamab in Mantle Cell Lymphoma:
https://ashpublications.org/blood/article/140/Supplement%201/178/489039
51 حلقات
Manage episode 386758190 series 3369804
In this episode, we delve into the weeds of bispecific antibodies across lymphomas with Dr. Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, Australia. Here are the key articles we discussed:
1. Glofitamab for Relapsed/Refractory DLBCL:
https://pubmed.ncbi.nlm.nih.gov/36507690/
2. Long-term follow-up data on blinatumomab in relapsed/refractory B-cell NHL:
https://pubmed.ncbi.nlm.nih.gov/31451445/
3. Phase 1/2 study of epcoritamab in relapsed/refractory DLBCL:
https://pubmed.ncbi.nlm.nih.gov/36548927/
4. Phase 2 trial of mosunetuzumab in relapsed/refractory follicular lymphoma:
https://pubmed.ncbi.nlm.nih.gov/35803286/
5. Phase 1 trial of odronextamab in relapsed/refractory B-cell NHL:
https://pubmed.ncbi.nlm.nih.gov/35366963/
6. Epcoritamab + R2 in high-risk follicular lymphoma:
https://meetings.asco.org/abstracts-presentations/218265
7. Glofitamab in Mantle Cell Lymphoma:
https://ashpublications.org/blood/article/140/Supplement%201/178/489039
51 حلقات
Alle episoder
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.